Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Feeding Infant Formula With Enriched Protein Fractions in the US

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Singleton, 0-90 days of age at randomization~* Term infant with birth weight of a minimum of 2500 grams~* Receiving at least 75% of the recommended caloric intake from cow's milk-based infant formula~* Parent or legally authorized representative attending study visits reads, understands, and speaks English~* Signed Informed Consent and Protected Health Information authorization~Exclusion Criteria:~* History of underlying metabolic or chronic disease, congenital malformation, or immunocompromised~* Feeding difficulties or formula intolerance~* Infant born small for gestational age~* Infant born from a mother who was diabetic at childbirth~* History of seizures or neurological disorders or infant with known head/brain disease/injury

- Gender: ALL
- Minimum Age: None
- Maximum Age: 90 Days
- Healthy Volunteers: t

Study Arms:
- Cow's milk-based infant formula (Type: ACTIVE_COMPARATOR): None
- Cow milk-based infant formula with enriched protein fractions (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).